The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Multidrug evolutionary strategies to reverse antibiotic resistance
Open accessAbstract
Evolving antibiotic rescue stratagems: Antibiotic resistance threatens to put modern medicine into reverse. But we are not at the end of our options for currently available drugs. Baym et al. review what can be done by using combinations of antibiotics to circumvent bacteria's evolutionary strategies. For instance, resistance to one drug may cause sensitivity to another, the effectiveness of two drugs can be synergized by a resistance mutation, and some negative drug interactions may even be beneficial in selecting against resistance. Although not simple to assess, drug combinations still have something to offer for the development of sorely needed anti-infectives. Science , this issue p. 10.1126/science.aad3292
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
Bacterial Quorum Sensing: Its Role in Virulence and Possibilities for Its Control
Rutherford, S. T., & Bassler, B. L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012427 · Cited by 2,129
Three Decades of β-Lactamase Inhibitors
Drawz, S. M., & Bonomo, R. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00037-09 · Cited by 1,709
Molecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
Tackling antibiotic resistance
Bush, K., Courvalin, P., Dantas, G., Davies, J., Eisenstein, B., Huovinen, P., Jacoby, G. A., Kishony, R., Kreiswirth, B. N., Kutter, E., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2693 · Cited by 1,062
Self-citationKatayama, Y., Ito, T., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1549-1555.2000 · Cited by 1,038
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
Allison, K. R., Brynildsen, M. P., & Collins, J. J. (2011) · Nature · doi:10.1038/nature10069 · Cited by 1,025
What is a resistance gene? Ranking risk in resistomes
Martínez, J. L., Coque, T. M., & Baquero, F. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3399 · Cited by 1,001
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus
Lehar, S. M., Pillow, T., Xu, M., Staben, L., Kajihara, K. K., Vandlen, R., DePalatis, L., Raab, H., Hazenbos, W. L., Hiroshi Morisaki, J., et al. (2015) · Nature · doi:10.1038/nature16057 · Cited by 838 · cited 1×
“Several complementary strategies for evolutionarily robust bacterial inhibition have been suggested, including suppression of virulence (21–23), persistence (24), and quorum sensing (25, 26), as well as novel targeting strategies to allow higher effective doses (27); however, they are outside the scope of this review.”
Combination Therapy for Treatment of Infections with Gram-Negative Bacteria
Tamma, P. D., Cosgrove, S. E., & Maragakis, L. L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05041-11 · Cited by 836
Further Observations on Penicillin
Abraham, E. P., Chain, E., Fletcher, C. M., Gardner, A. D., Heatley, N. G., Jennings, M. A., & Florey, H. W. (1941) · The Lancet · doi:10.1016/s0140-6736(00)72122-2 · Cited by 821 · cited 1×
“Since the earliest days of antibiotics, resistance has been observed and recognized as a challenge (1).”
Okusu, H., Ma, D., & Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.1.306-308.1996 · Cited by 814
Multicomponent therapeutics for networked systems
Keith, C. T., Borisy, A. A., & Stockwell, B. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1609 · Cited by 769
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection
Toprak, E., Veres, A., Michel, J.-B., Chait, R., Hartl, D. L., & Kishony, R. (2012) · Nature Genetics · doi:10.1038/ng.1034 · Cited by 764
Self-citationStermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., & Lewis, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030540597 · Cited by 761
Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus
Reading, C., & Cole, M. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.5.852 · Cited by 739
Phenotypic Landscape of a Bacterial Cell
Nichols, R. J., Sen, S., Choo, Y. J., Beltrao, P., Zietek, M., Chaba, R., Lee, S., Kazmierczak, K. M., Lee, K. J., Wong, A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.052 · Cited by 713
Positive selection for loss of tetracycline resistance
Bochner, B. R., Huang, H. C., Schieven, G. L., & Ames, B. N. (1980) · Journal of Bacteriology · doi:10.1128/jb.143.2.926-933.1980 · Cited by 695
Bacterial charity work leads to population-wide resistance
Lee, H. H., Molla, M. N., Cantor, C. R., & Collins, J. J. (2010) · Nature · doi:10.1038/nature09354 · Cited by 638
Optimization of lag time underlies antibiotic tolerance in evolved bacterial populations
Fridman, O., Goldberg, A., Ronin, I., Shoresh, N., & Balaban, N. Q. (2014) · Nature · doi:10.1038/nature13469 · Cited by 613
Bacterial uptake of aminoglycoside antibiotics
Taber, H. W., Mueller, J. P., Miller, P. F., & Arrow, A. S. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.4.439-457.1987 · Cited by 598
Antibiotics in agriculture and the risk to human health: how worried should we be?
Chang, Q., Wang, W., Regev‐Yochay, G., Lipsitch, M., & Hanage, W. P. (2015) · Evolutionary Applications · doi:10.1111/eva.12185 · Cited by 562
Bradley, P., Gordon, N. C., Walker, T. M., Dunn, L., Heys, S., Huang, B., Earle, S., Pankhurst, L. J., Anson, L., de Cesare, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms10063 · Cited by 556
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
King, A. M., Reid-Yu, S. A., Wang, W., King, D. T., De Pascale, G., Strynadka, N. C., Walsh, T. R., Coombes, B. K., & Wright, G. D. (2014) · Nature · doi:10.1038/nature13445 · Cited by 554
Targeting virulence: can we make evolution-proof drugs?
Allen, R. C., Popat, R., Diggle, S. P., & Brown, S. P. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3232 · Cited by 532
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Antibiotics in animal feed and their role in resistance development
Wegener, H. C. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.09.009 · Cited by 517
Evaluating treatment protocols to prevent antibiotic resistance
Bonhoeffer, S., Lipsitch, M., & Levin, B. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12106 · Cited by 487
Imamovic, L., & Sommer, M. O. A. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006609 · Cited by 444
Molecular mechanisms of antibiotic resistance
Wright, G. D. (2011) · Chemical Communications · doi:10.1039/c0cc05111j · Cited by 443
Antibiotic interactions that select against resistance
Chait, R., Craney, A., & Kishony, R. (2007) · Nature · doi:10.1038/nature05685 · Cited by 439
Self-citationSzybalski, W., & Bryson, V. (1952) · Journal of Bacteriology · doi:10.1128/jb.64.4.489-499.1952 · Cited by 421
Safdar, N., Handelsman, J., & Maki, D. G. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01108-9 · Cited by 417
Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes
Lieberman, T. D., Michel, J.-B., Aingaran, M., Potter-Bynoe, G., Roux, D., Davis, M. R., Skurnik, D., Leiby, N., LiPuma, J. J., Goldberg, J. B., et al. (2011) · Nature Genetics · doi:10.1038/ng.997 · Cited by 365
Self-citationFluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter
Neyfakh, A. A., Borsch, C. M., & Kaatz, G. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.128 · Cited by 361
Drug interactions and the evolution of antibiotic resistance
Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2133 · Cited by 350
Self-citationFunctional classification of drugs by properties of their pairwise interactions
Yeh, P., Tschumi, A. I., & Kishony, R. (2006) · Nature Genetics · doi:10.1038/ng1755 · Cited by 350
Self-citationBacterial evolution of antibiotic hypersensitivity
Lázár, V., Pal Singh, G., Spohn, R., Nagy, I., Horváth, B., Hrtyan, M., Busa‐Fekete, R., Bogos, B., Méhi, O., Csörgő, B., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.57 · Cited by 350
Pagès, J.-M., & Amaral, L. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.12.011 · Cited by 329
Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B
Vincent, B. M., Lancaster, A. K., Scherz-Shouval, R., Whitesell, L., & Lindquist, S. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001692 · Cited by 322
Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary
Chow, J. W., & Yu, V. L. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(98)00060-0 · Cited by 320
Systematic exploration of synergistic drug pairs
Cokol, M., Chua, H. N., Tasan, M., Mutlu, B., Weinstein, Z. B., Suzuki, Y., Nergiz, M. E., Costanzo, M., Baryshnikova, A., Giaever, G., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.71 · Cited by 315
A Strategy for Antagonizing Quorum Sensing
Chen, G., Swem, L. R., Swem, D. L., Stauff, D. L., O'Loughlin, C. T., Jeffrey, P. D., Bassler, B. L., & Hughson, F. M. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.003 · Cited by 312
Collateral sensitivity as a strategy against cancer multidrug resistance
Pluchino, K. M., Hall, M. D., Goldsborough, A. S., Callaghan, R., & Gottesman, M. M. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.03.002 · Cited by 305
Accelerated evolution of resistance in multidrug environments
Hegreness, M., Shoresh, N., Damian, D., Hartl, D., & Kishony, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805965105 · Cited by 300
Self-citationOz, T., Guvenek, A., Yildiz, S., Karaboga, E., Tamer, Y. T., Mumcuyan, N., Ozan, V. B., Senturk, G. H., Cokol, M., Yeh, P., et al. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu191 · Cited by 275
Lieberman, T. D., Flett, K. B., Yelin, I., Martin, T. R., McAdam, A. J., Priebe, G. P., & Kishony, R. (2014) · Nature Genetics · doi:10.1038/ng.2848 · Cited by 270
Self-citationPrediction of antibiotic resistance by gene expression profiles
Suzuki, S., Horinouchi, T., & Furusawa, C. (2014) · Nature Communications · doi:10.1038/ncomms6792 · Cited by 267
Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance
Kim, S., Lieberman, T. D., & Kishony, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409800111 · Cited by 264
Self-citationRenau, T. E., Léger, R., Flamme, E. M., Sangalang, J., She, M. W., Yen, R., Gannon, C. L., Griffith, D., Chamberland, S., Lomovskaya, O., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9904598 · Cited by 260
Inhibitor-resistant TEM -lactamases: phenotypic, genetic and biochemical characteristics
Chaibi, E. B., Sirot, D., Paul, G., & Labia, R. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.447 · Cited by 256
Human Health Hazards from Antimicrobial‐Resistant Escherichia coli of Animal Origin
Hammerum, A. M., & Heuer, O. E. (2009) · Clinical Infectious Diseases · doi:10.1086/597292 · Cited by 251
Lázár, V., Nagy, I., Spohn, R., Csörgő, B., Györkei, Á., Nyerges, Á., Horváth, B., Vörös, A., Busa-Fekete, R., Hrtyan, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5352 · Cited by 249
Die quantitativen Probleme der Pharmakologie
Loewe, S. (1928) · Ergebnisse der Physiologie · doi:10.1007/bf02322290 · Cited by 229
Nonoptimal microbial response to antibiotics underlies suppressive drug interactions
Bollenbach, T., Quan, S., Chait, R., & Kishony, R. (2009) · Cell · doi:10.1016/j.cell.2009.10.025 · Cited by 227
Self-citationCombating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation
Smith, P. A., & Romesberg, F. E. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.27 · Cited by 222
De Beenhouwer, H., Lhiang, Z., Jannes, G., Mijs, W., Machtelinckx, L., Rossau, R., Traore, H., & Portaels, F. (1995) · Tubercle and Lung Disease · doi:10.1016/0962-8479(95)90009-8 · Cited by 220
Treatment of antiretroviral-drug-resistant HIV-1 infection
Deeks, S. G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15022-2 · Cited by 219
Drug interactions modulate the potential for evolution of resistance
Michel, J.-B., Yeh, P. J., Chait, R., Moellering, R. C., & Kishony, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800944105 · Cited by 215
Self-citationResisting resistance: new chemical strategies for battling superbugs
Wright, G. D. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00126-5 · Cited by 203
Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance
Vega, N. M., Allison, K. R., Samuels, A. N., Klempner, M. S., & Collins, J. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308085110 · Cited by 184
Munck, C., Gumpert, H. K., Wallin, A. I. N., Wang, H. H., & Sommer, M. O. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009940 · Cited by 178
Antibiotic effectiveness: Balancing conservation against innovation
Laxminarayan, R. (2014) · Science · doi:10.1126/science.1254163 · Cited by 170
Sjlund, M., Wreiber, K., Andersson, D. I., Blaser, M. J., & Engstrand, L. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-6-200309160-00011 · Cited by 169
Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness
Lenski, R. E., Simpson, S. C., & Nguyen, T. T. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.11.3140-3147.1994 · Cited by 166
Optimal Drug Synergy in Antimicrobial Treatments
Torella, J. P., Chait, R., & Kishony, R. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000796 · Cited by 162
Self-citationSynergistic, collaterally sensitive β-lactam combinations suppress resistance in MRSA
Gonzales, P. R., Pesesky, M. W., Bouley, R., Ballard, A., Biddy, B. A., Suckow, M. A., Wolter, W. R., Schroeder, V. A., Burnham, C.-A. D., Mobashery, S., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1911 · Cited by 160
Delayed commitment to evolutionary fate in antibiotic resistance fitness landscapes
Palmer, A. C., Toprak, E., Baym, M., Kim, S., Veres, A., Bershtein, S., & Kishony, R. (2015) · Nature Communications · doi:10.1038/ncomms8385 · Cited by 158
Self-citationFitness cost of antibiotic susceptibility during bacterial infection
Roux, D., Danilchanka, O., Guillard, T., Cattoir, V., Aschard, H., Fu, Y., Angoulvant, F., Messika, J., Ricard, J.-D., Mekalanos, J. J., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab1621 · Cited by 156
Discovery of a Small Molecule that Blocks Wall Teichoic Acid Biosynthesis in Staphylococcus aureus
Swoboda, J. G., Meredith, T. C., Campbell, J., Brown, S. L., Suzuki, T., Bollenbach, T., Malhowski, A. J., Kishony, R., Gilmore, M. S., & Walker, S. (2009) · ACS Chemical Biology · doi:10.1021/cb900151k · Cited by 152
Self-citationDragosits, M., Mozhayskiy, V., Quiñones-Soto, S., Park, J., & Tagkopoulos, I. (2013) · Molecular Systems Biology · doi:10.1038/msb.2012.76 · Cited by 150
Opposing effects of target overexpression reveal drug mechanisms
Palmer, A. C., & Kishony, R. (2014) · Nature Communications · doi:10.1038/ncomms5296 · Cited by 147
Self-citationNguyen, T. N., Phan, Q.-T., DUONG, L. P., Bertrand, K. P., & Lenski, R. E. (1989) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040545 · Cited by 142
Vieira, A. R., Collignon, P., Aarestrup, F. M., McEwen, S. A., Hendriksen, R. S., Hald, T., & Wegener, H. C. (2011) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2011.0950 · Cited by 139
Skurnik, D., Roux, D., Cattoir, V., Danilchanka, O., Lü, X., Yoder-Himes, D. R., Han, K., Guillard, T., Jiang, D., Gaultier, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221552110 · Cited by 137
Fitness Cost of VanA-Type Vancomycin Resistance in Methicillin-Resistant Staphylococcus aureus
Foucault, M.-L., Courvalin, P. M., & Grillot‐Courvalin, C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01702-08 · Cited by 137
Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance
Moreno-Gámez, S., Hill, A. L., Rosenbloom, D. I. S., Petrov, D. A., Nowak, M. A., & Pennings, P. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424184112 · Cited by 136
Genetic Studies on Microbial Cross Resistance to Toxic Agents
Szybalski, W. (1954) · Applied Microbiology · doi:10.1128/am.2.2.57-63.1954 · Cited by 135
Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance
Pokrovskaya, V., & Baasov, T. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.508069 · Cited by 132
Novel Inhibitors of Erm Methyltransferases from NMR and Parallel Synthesis
Hajduk, P. J., Dinges, J., Schkeryantz, J. M., Janowick, D. A., Kaminski, M., Tufano, M. D., Augeri, D. J., Petros, A. M., Nienaber, V. L., Zhong, P., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990293a · Cited by 119
van der Zee, A., Roorda, L., Bosman, G., Fluit, A. C., Hermans, M. H. A., Smits, P. H. M., van der Zanden, A. G., Witt, R. T., van Coppenraet, L. E. S. B., Stuart, J. W. T. C., et al. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-27 · Cited by 112
Markham, P. N., & Neyfakh, A. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2673 · Cited by 111
Gallium-mediated siderophore quenching as an evolutionarily robust antibacterial treatment
Ross-Gillespie, A., Weigert, M., Brown, S. P., & Kümmerli, R. (2014) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eou003 · Cited by 104
Petersen, T. N., Rasmussen, S., Hasman, H., Carøe, C., Bælum, J., Schultz, A. C., Bergmark, L., Svendsen, C. A., Lund, O., Sicheritz‐Pontén, T., et al. (2015) · Scientific Reports · doi:10.1038/srep11444 · Cited by 100
Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax
Hastings, M. D., & Sibley, C. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182295999 · Cited by 97
Cycling Empirical Antibiotic Therapy in Hospitals: Meta-Analysis and Models
Wiesch, P. A. Z., Kouyos, R. D., Abel, S., Viechtbauer, W., & Bonhoeffer, S. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004225 · Cited by 94
Kollef, M. H. (2006) · Clinical Infectious Diseases · doi:10.1086/504484 · Cited by 89
Systematic discovery of drug interaction mechanisms
Chevereau, G., & Bollenbach, T. (2015) · Molecular Systems Biology · doi:10.15252/msb.20156098 · Cited by 89
The path of least resistance: aggressive or moderate treatment?
Kouyos, R. D., Metcalf, C. J. E., Birger, R. B., Klein, E. Y., Wiesch, P. A. Z., Ankomah, P., Arinaminpathy, N., Bogich, T. L., Bonhoeffer, S., Brower, C. H., et al. (2014) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2014.0566 · Cited by 88
Gelder, L. D., Ponciano, J. M., Abdo, Z., Joyce, P., Forney, L. J., & Top, E. M. (2004) · Genetics · doi:10.1534/genetics.104.033431 · Cited by 76
A Forward Chemical Screen Identifies Antibiotic Adjuvants in Escherichia coli
Taylor, P. L., Rossi, L., Pascale, G. D., & Wright, G. D. (2012) · ACS Chemical Biology · doi:10.1021/cb300269g · Cited by 74
Nelson, M. L., Park, B. H., Andrews, J. S., Georgian, V. A., Thomas, R. C., & Levy, S. B. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00055a008 · Cited by 71
7-Hydroxytropolone: an inhibitor of aminoglycoside-2"-O-adenylyltransferase
Allen, N. E., Alborn, W. E., Hobbs, J. N., & Kirst, H. A. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.5.824 · Cited by 70
Persistence of ResistantStaphylococcus epidermidisafter Single Course of Clarithromycin
Sjölund, M., Tano, E., Blaser, M. J., Andersson, D. I., & Engstrand, L. G. (2005) · Emerging infectious diseases · doi:10.3201/eid1109.050124 · Cited by 63
Lukens, A. K., Ross, L. S., Heidebrecht, R. W., Gamo, F., Lafuente-Monasterio, M. J., Booker, M. L., Hartl, D. L., Wiegand, R. C., & Wirth, D. F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320886110 · Cited by 63
McClure, N. S., & Day, T. (2014) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2014.1861 · Cited by 61
Uncovering Scaling Laws to Infer Multidrug Response of Resistant Microbes and Cancer Cells
Wood, K. B., Wood, K. C., Nishida, S., & Cluzel, P. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.007 · Cited by 56
A Differential Drug Screen for Compounds That Select Against Antibiotic Resistance
Chait, R., Shrestha, S., Shah, A. K., Michel, J.-B., & Kishony, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015179 · Cited by 54
Self-citationLi, Q., Lee, J. Y., Castillo, R. S., Hixon, M. S., Pujol, C. J., Doppalapudi, V. R., Shepard, H. M., Wahl, G. M., Lobl, T. J., & Chan, M. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1262-1268.2002 · Cited by 44
Gadamski, G., Ciarka, D., Gressel, J., & Gawronski, S. W. (2000) · Weed Science · doi:10.1614/0043-1745(2000)048[0176:ncritr]2.0.co;2 · Cited by 40
Griffith, J. K., Kogoma, T., Corvo, D. L., Anderson, W. L., & Kazim, A. L. (1988) · Journal of Bacteriology · doi:10.1128/jb.170.2.598-604.1988 · Cited by 31
Gressel, J., & Segel, L. A. (1990) · Zeitschrift für Naturforschung C · doi:10.1515/znc-1990-0528 · Cited by 29
An unusual interaction between the target of nalidixic acid and novobiocin
Chao, L. (1978) · Nature · doi:10.1038/271385a0 · Cited by 28
Large-Scale Identification and Analysis of Suppressive Drug Interactions
Cokol, M., Weinstein, Z., Yılancıoğlu, K., Tasan, M., Doak, A. K., Cansever, D., Mutlu, B., Li, S., Rodriguez‐Esteban, R., Akhmedov, M., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.02.012 · Cited by 27
A Hybrid Drug Limits Resistance by Evading the Action of the Multiple Antibiotic Resistance Pathway
Wang, K. K., Stone, L. K., Lieberman, T. D., Shavit, M., Baasov, T., & Kishony, R. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv243 · Cited by 27
Self-citationThe optimal deployment of synergistic antibiotics: a control-theoretic approach
Peña‐Miller, R., Laehnemann, D., Schulenburg, H., Ackermann, M., & Beardmore, R. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0279 · Cited by 25
Cited by
Review on plant antimicrobials: a mechanistic viewpoint
Khameneh, B., Iranshahy, M., Soheili, V., & Fazly Bazzaz, B. S. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0559-6 · Cited by 891
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 820
Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
The evolution of antibiotic resistance
MacLean, R. C., & San Millan, A. (2019) · Science · doi:10.1126/science.aax3879 · Cited by 614
The challenge of antimicrobial resistance: What economics can contribute
Roope, L. S. J., Smith, R. D., Pouwels, K. B., Buchanan, J., Abel, L., Eibich, P., Butler, C. C., Tan, P. S., Walker, A. S., Robotham, J. V., et al. (2019) · Science · doi:10.1126/science.aau4679 · Cited by 575
Metadata
- Authors
- Baym, M., Stone, L. K., & Kishony, R.
- Venue
- Science
- Published
- 2016-01
- Volume
- 351
- Issue
- 6268
- Pages
- aad3292-aad3292
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2222642144
- Cited by
- 710
- References
- 109
- FWCI
- 16.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.